Quality & Compliance

Viral contamination can have devastating effects. But innovations upstream can help prevent that.

Helping to meet demands and reduce shortages... Is continuous manufacturing the way forward for pharma?

Sitting Down With... David Schoneker, Global Regulatory Director, Strategic Relationships at Colorcon.

Innovation in glass continues to be a key enabler for allowing pharma manufacturers to make better, safer products for patients.

EU will allow companies to carry out QC testing in the UK after a "no deal" Brexit, at least under certain conditions and for a limited time.

If you or your supplier are working with animal-derived components, you run the risk of exposing patients to dangerous contaminations.

Meet the analytical experts working at the cutting-edge of pharma analytics to ensure the safety of medicines.

When it comes to the crunch – the swab test – planning and preparation are the key to the best performance.

Rather than fearing the unknown, the concept of optionality can help you better manage it.

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.